How the standard of care in rare diseases can be affected by regional challenges

Join this engaging session which will address the regional differences and challenges encountered with rare diseases. Firstly, Richard White, COO at Oxford PharmaGenesis will explore how we can unravel the regional conundrum of managing rare diseases, followed by an interview with Arzu Mulayim, Medical Director of the MENA region at PTC Therapeutics. Arzu will give more detailed insights into the challenges of managing patients with rare disease in the MENA region